Digital Smoking Cessation Programs in HIV Care
Digital smoking cessation programs HIV provide tailored support for people living with HIV. These programs enable remote access to evidence-based cessation tools. Digital therapeutics show promising effectiveness in this underserved population.
Endocannabinoid System and Cannabis Dosing: Clinical Research
This article reviews endocannabinoid system cannabis dosing research and its clinical implications. Understanding cannabis dosing is essential for optimizing therapeutic outcomes. Clinical research highlights the role of the endocannabinoid system in…
Endocannabinoid System: Cannabis Role in HIV Smoking Cessation
The endocannabinoid system cannabis hiv smoking cessation research highlights digital therapeutics tailored for people living with HIV. These tools show strong feasibility and acceptability as smoking cessation aids. This pilot trial suggests…
Cannabis and HIV Research Associate – Psychiatry – 139327 – Careers at UC San Diego
The cannabis hiv research associate psychiatry position at UC San Diego highlights growing institutional focus on cannabis in HIV care. This role supports research on cannabis applications for symptom management and drug interactions in HIV patients. It…
Cannabis Trial in HIV Patients Fell Far Short of Enrollment Goals, Revealing Key Barriers to Cannabinoid Research
The cannabinoid HIV trial feasibility study approached 205 individuals but enrolled only 10, revealing major barriers such as cannabis-related stigma and visit burdens. This low enrollment rate highlights challenges in conducting cannabinoid clinical…
One in Four Women with HIV Used Cannabis in 18 Months, With Most Relying on Smoking
A 2025 study reveals cannabis use patterns women with HIV, showing 27% prevalence over 18 months. Most women relied on smoking cannabis, with 15% using daily. These patterns highlight the need for routine clinical screening in HIV care.
Digital Therapeutics for Smoking Cessation in HIV Patients
HIV smoking cessation digital therapeutics show promise in engaging people living with HIV for tobacco cessation. Clinical trial data supports feasibility and acceptability of these tools. Technology-based interventions can reach this population…
Study: Low-Dose CBD Found Safe for People With HIV on Long-Term Antiretroviral Therapy
This study investigates cbd safety hiv patients on long-term antiretroviral therapy. Results indicate low-dose CBD is well tolerated without adverse effects. Understanding cbd safety hiv patients is crucial due to potential drug interactions and immune…
Cannabis for Symptom Relief in HIV and Cancer: A Map of What We Know—and What We Don’t
Cannabis symptom management HIV cancer is an emerging field with limited but growing observational evidence. This review highlights gaps in dosing, safety, and effectiveness data. Patients and clinicians face uncertainty while seeking symptom relief…
Endocannabinoid System Research: Cannabis & HIV Smoking
Digital therapeutics tailored to people living with HIV show promising feasibility and acceptability as a scalable approach to smoking cessation. Tobacco use remains a leading driver of preventable illness and death among people with HIV, making…